Profund Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-864
| Closed | -$286K | – | 1343 |
|
|
2022
Q1 | $286K | Sell |
864
-133
| -13% | -$40.9K | 0.01% | 977 |
|
|
2021
Q4 | $358K | Buy |
997
+32
| +3% | +$10.8K | 0.01% | 846 |
|
|
2021
Q3 | $314K | Buy |
965
+30
| +3% | +$10.2K | 0.01% | 911 |
|
|
2021
Q2 | $292K | Buy |
935
+13
| +1% | +$3.99K | 0.01% | 1091 |
|
|
2021
Q1 | $294K | Sell |
922
-135
| -13% | -$43.2K | 0.01% | 994 |
|
|
2020
Q4 | $343K | Buy |
1,057
+44
| +4% | +$12.2K | 0.02% | 742 |
|
|
2020
Q3 | $281K | Sell |
1,013
-254
| -20% | -$73.2K | 0.01% | 697 |
|
|
2020
Q2 | $306K | Buy |
+1,267
| New | +$254K | 0.02% | 591 |
|
|
2020
Q1 | – | Sell |
-1,275
| Closed | -$218K | – | 1213 |
|
|
2019
Q4 | $218K | Buy |
1,275
+96
| +8% | +$17.8K | 0.01% | 1127 |
|
|
2019
Q3 | $210K | Sell |
1,179
-152
| -11% | -$32.9K | 0.01% | 1152 |
|
|
2019
Q2 | $347K | Sell |
1,331
-347
| -21% | -$92.1K | 0.02% | 849 |
|
|
2019
Q1 | $479K | Buy |
1,678
+73
| +5% | +$24.3K | 0.02% | 651 |
|
|
2018
Q4 | $522K | Sell |
1,605
-396
| -20% | -$138K | 0.03% | 471 |
|
|
2018
Q3 | $900K | Buy |
2,001
+647
| +48% | +$255K | 0.03% | 442 |
|
|
2018
Q2 | $554K | Sell |
1,354
-5,118
| -79% | -$1.85M | 0.02% | 708 |
|
|
2018
Q1 | $1.88M | Buy |
6,472
+1,498
| +30% | +$380K | 0.08% | 220 |
|
|
2017
Q4 | $932K | Sell |
4,974
-597
| -11% | -$111K | 0.04% | 489 |
|
|
2017
Q3 | $939K | Buy |
5,571
+501
| +10% | +$75.8K | 0.04% | 437 |
|
|
2017
Q2 | $727K | Sell |
5,070
-1,286
| -20% | -$173K | 0.03% | 523 |
|
|
2017
Q1 | $796K | Buy |
6,356
+398
| +7% | +$46.1K | 0.04% | 553 |
|
|
2016
Q4 | $671K | Sell |
5,958
-185
| -3% | -$21.4K | 0.03% | 697 |
|
|
2016
Q3 | $790K | Buy |
6,143
+734
| +14% | +$87.9K | 0.04% | 499 |
|
|
2016
Q2 | $591K | Sell |
5,409
-1,070
| -17% | -$106K | 0.03% | 680 |
|
|
2016
Q1 | $614K | Sell |
6,479
-2,611
| -29% | -$220K | 0.03% | 597 |
|
|
2015
Q4 | $821K | Buy |
9,090
+1,262
| +16% | +$107K | 0.04% | 444 |
|
|
2015
Q3 | $726K | Sell |
7,828
-1,308
| -14% | -$115K | 0.04% | 386 |
|
|
2015
Q2 | $601K | Sell |
9,136
-2,919
| -24% | -$194K | 0.02% | 672 |
|
|
2015
Q1 | $863K | Buy |
12,055
+5,064
| +72% | +$275K | 0.03% | 555 |
|
|
2014
Q4 | $266K | Buy |
+6,991
| New | +$221K | 0.01% | 1197 |
|
|
2014
Q3 | – | Sell |
-9,534
| Closed | -$240K | – | 1472 |
|
|
2014
Q2 | $240K | Buy |
9,534
+313
| +3% | +$7.29K | 0.01% | 1338 |
|
|
2014
Q1 | $240K | Sell |
9,221
-2,550
| -22% | -$70.5K | 0.01% | 1347 |
|
|
2013
Q4 | $315K | Sell |
11,771
-1,707
| -13% | -$42.2K | 0.01% | 1365 |
|
|
2013
Q3 | $257K | Buy |
+13,478
| New | +$308K | 0.01% | 1388 |
|
Other funds holding ABMD
GIM
BCM
Profund Advisors's ABMD Position: Q2 2022 in Review
Profund Advisors sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 864 shares — an estimated $286K sold.
Profund Advisors first reported a position in ABMD in Q3 2013 and held it in 33 quarters. The position peaked at $1.88M in Q1 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.
- Profund Advisors reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
- Profund Advisors sold 864 Abiomed Inc shares in Q2 2022, an estimated $286K.
- Profund Advisors first reported a position in Abiomed Inc in Q3 2013 and held it in 33 quarters.
- Profund Advisors's Abiomed Inc position peaked at $1.88M in Q1 2018.
- 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.
Based on Profund Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.